NR

Nishant Rastogi

Head of Transactions at New Rhein Healthcare Investors

New York City Metropolitan Area

Overview

Nishant Rastogi is currently the VP, Head of Transactions at New Rhein Healthcare Investors, specializing in life sciences investments. With a background in venture capital and management consulting, he has served on the boards of various healthcare companies and has extensive experience in impact investing and financial analysis. Highlights of Nishant's career include his role as a member of the board of directors at Corsair Pharma and his involvement in investments at companies like Butterfly Medical and Neuraptive Therapeutics.

Work Experience

NR

New Rhein Healthcare Investors

VP, Head of Transactions
2018 - Current
New Rhein is an operationally-oriented life sciences investment fund that applies a private equity model to biotech/medtech investing. At the core of New Rhein's strategy is a commitment to actively manage the value creation process. This involves taking substantial stakes in a select number of companies to enable focus on successful product development and commercialization, while mitigating science-based risk. New Rhein's team is comprised of former senior executives from renowned pharmaceutical companies, who bring industry-specific expertise to each deal.

New Rhein is a global venture capital firm investing in healthcare.

newrhein.com

CP